Edition:
United Kingdom

Cadila Healthcare Ltd (CADI.NS)

CADI.NS on National Stock Exchange of India

343.05INR
22 May 2018
Change (% chg)

Rs-10.10 (-2.86%)
Prev Close
Rs353.15
Open
Rs353.15
Day's High
Rs359.00
Day's Low
Rs341.20
Volume
897,340
Avg. Vol
960,438
52-wk High
Rs560.00
52-wk Low
Rs341.20

Select another date:

Wed, May 2 2018

BRIEF-Cadila Healthcare Gets Exit Price For Sale Of Shares To Bayer (South East Asia)

* CADILA HEALTHCARE - GOT EXIT PRICE FOR SALE OF SHARES TO BAYER (SOUTH EAST ASIA) PTE LTD IN TERMS OF JV AGREEMENT Source text: http://bit.ly/2HNe3Uu Further company coverage:

BRIEF-Cadila Healthcare Says Zydus Received Final Approval From USFDA For Bumetanide Tablets USP

* SAYS ZYDUS RECEIVED FINAL APPROVAL FROM USFDA FOR BUMETANIDE TABLETS USP Source text for Eikon: Further company coverage:

BRIEF-Cadila Healthcare To Sell 12.5 Mln Shares Of JV To Bayer (South East Asia)

* SAYS CO IS SELLING 12.5 MILLION SHARES OF JV TO BAYER (SOUTH EAST ASIA) PTE BY EXECUTING SHARE PURCHASE DEAL Source text - https://reut.rs/2r4g6ft Further company coverage:

BRIEF-Cadila Healthcare Says Zydus Gets U.S. FDA Final Nod For Methylprednisolone Tablets USP, Cinacalcet Hydrochloride Tablets

* SAYS ZYDUS GETS FINAL APPROVAL FROM USFDA FOR METHYLPREDNISOLONE TABLETS USP AND CINACALCET HYDROCHLORIDE TABLETS Source text - http://bit.ly/2Hry5Yw Further company coverage:

BRIEF-Cadila Healthcare Says Zydus Gets Final Approval From U.S. FDA For Diclofenac Sodium Topical Solution

* SAYS ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR DICLOFENAC SODIUM TOPICAL SOLUTION

BRIEF-India's Cadila Healthcare Says No Observation Issued For Topical Unit

* SAYS TOPICAL FACILITY SUCCESSFULLY COMPLETES USFDA INSPECTION

BRIEF-Cadila Healthcare Says ‍Zydus Gets U.S. FDA Nod For Metoprolol Succinate Extended-Release Tablets USP​

* SAYS ‍ZYDUS RECEIVES FINAL APPROVAL FROM USFDA FOR METOPROLOL SUCCINATE EXTENDED-RELEASE TABLETS USP​ Source text - http://bit.ly/2pEyVGd Further company coverage:

BRIEF-Cadila Healthcare Says Zydus Gets Final Nod From U.S. FDA For Tizanidine Tablets USP

* SAYS ZYDUS RECEIVES FINAL APPROVAL FROM U.S. FDA FOR TIZANIDINE TABLETS USP Source text - http://bit.ly/2p5iSkn Further company coverage:

BRIEF-Cadila Healthcare's ‍Zydus Partners With Medicure To Launch Zypitamag In U.S.​

* UNIT ‍ZYDUS PARTNERS WITH MEDICURE TO LAUNCH ITS NDA PRODUCT, ZYPITAMAG (PITAVASTATIN) IN U.S.​ Source text - http://bit.ly/2oYA0Yx Further company coverage:

BRIEF-Cadila Healthcare's ‍Zydus Gets Final Nod From U.S. FDA For Sedative Injection​

* UNIT ‍ZYDUS GETS FINAL NOD FROM U.S. FDA FOR DEXMEDETOMIDINE HYDROCHLORIDE INJECTION

Select another date: